SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is drawing heavy retail attention after positive Phase 2 weight-loss maintenance and tolerability data for VK2735, with sentiment on the platform shifting to extremely bullish on elevated message volume. Bulls argue the results de-risk the drug ahead of Phase 3, fueling short-squeeze talk and renewed takeover speculation, while skeptics point to the muted stock reaction, sell-the-news profit taking, and dilution concerns tied to the company's $500 million shelf offering.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending after founder Patrick Soon-Shiong teased a potential push into blockchain-based tokenized stock trading at Nant, with traders speculating that tokenizing IBRX shares could curb naked short selling and squeeze elevated short interest. Skeptics caution the tease is not an official company announcement, while unconfirmed community speculation about Soon-Shiong's meeting with Turkey's president and a possible Anktiva expansion there adds to the chatter.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is drawing attention around its AI evaluation and red-teaming push, with traders pointing to the Innodata Muse announcement and the addition of former NSA Director Admiral Michael Rogers to the board as an AI-security signal. The community is split on what drove the rally, with some crediting the news and a broader AI-safety theme while others argue the move is a technical breakout amplified by a short squeeze rather than news-driven.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as retail traders react to CEO Ryan Cohen adding roughly $26.4 million in open-market sharesa follow-on purchase viewed by many as a signal of insider convictionamid a sustained runup in the stock and active discussion of warrants and a potential short squeeze. The community is split: some traders expect squeeze or buyback catalysts, while skeptics attribute the rally to bond-holder activity, declining short interest, or alleged market manipulation rather than Cohen's buying.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Discussion is fragmented rather than centered on a single catalyst, with the most common themes being oil price volatilityfuel costs, Royal Caribbean's fuel hedging versus unhedged peers CCL and NCLH, and Iran/Strait of Hormuz headlinesand a sharp debate over short-selling, which traders variously call manipulation or an easy short. Smaller threads criticize the company's resort acquisition, cite travel fears from a hantavirus outbreak on a cruise ship, and react to a beat-and-raise earnings report.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending amid a steep, sustained share decline following its removal from the S&P 500, with traders split on whether index-related selling drove the drop or was largely priced in as growth slows. Heavy short interest is fueling speculation of a potential short-covering rally, while criticism of managementover executive share sales, option repricing, and competition from Amazon, Google, and Metadrives much of the bearish commentary.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as traders question why the stock keeps selling off at the open and finishing red despite a run of positive company news, most notably CEO Dara Khosrowshahi's roughly $10 million open-market share purchase alongside additional COO insider buying that many in the community read as a strong accumulation signal. Reaction is split between bulls citing the insider purchases, new delivery partnerships, and Bill Ackman's backing as reasons to buy the weakness, and skeptics who suspect manipulation, sustained short pressure, or legitimate concern that Tesla and Waymo autonomous-vehicle competition threatens Uber's core business.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve is trending as traders speculate that a DEA decision to reschedule marijuana to Schedule III is imminent, with rumors circulating that an announcement could come after market close and hopes of a short squeeze if federal cannabis reform news hits. The buzz follows the company's NYSE uplisting and Q2 results, and the community is split between bulls anticipating a reform-driven rally and skeptics pointing to weakening technicals, bearish sentiment, and claims that shorts are hunting stop losses.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is rallying to a five-year high on a large quarterly revenue beatroughly $32 million versus expectations near $12 milliondriven by the launch of its FDA-approved TA-TMA treatment Yartemlea, with elevated short interest fueling widespread short-squeeze speculation among traders. The community is overwhelmingly bullish, though the discussion includes debate over how much of the short base is convertible-note hedging, whether the ~$1.5 billion market cap remains undervalued, and how much weight to give speculative European approval prospects.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

CSCO is drawing heavy attention as the stock sells off  down roughly 4%  despite a run of positive AI-related announcements, including expanded Nvidia and Supermicro partnerships and an AMD/Humain AI infrastructure deployment in Saudi Arabia, leaving many traders puzzled by the decline. The community is split: some blame short-selling pressure and low volume, others cite margin-compression concerns tied to the company's guidance, while bulls argue strong earnings and valuation make the drop unjustified.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vertex Touts Encouraging Data From 'Underappreciated' Kidney Drug

Vertex Pharmaceuticals reported positive Phase 2b data for inaxaplin in patients with APOL1-mediated kidney disease.read more...

Twin Moves: VRTX Rises On Kidney Disease Trial Results, MAZE Rallies Harder  

Equity

Vertex on Tuesday announced results from the mid-stage trial of its experimental pill, inaxaplin, in two groups of patients with APOL1-mediated kidney disease.


ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know

AbCellera shares skyrocket 121% as positive ABCL635 data, major partnerships and a stronger financial position boost investor confidence.

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.

Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from the Phase 2b AMPLIFIED study of inaxaplin in people with APOL1-mediated kidney disease (AMKD) and modest proteinuria and in people with AMKD and type 2 diabetes. In this study, inaxaplin was evaluated as a 45...

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why

Vertex Pharmaceuticals (VRTX) concluded the recent trading session at $508.34, signifying a -1.55% move from its prior day's close.

SION to Cut Workforce by Nearly Half After CF Study Failure, Stock Down

Sionna set to reduce its workforce by 46% after SION-719 fails a key CF study, shifting focus to SION-451 + SION-2222.

Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX (suzetrigine), a prescription non-opioid medicine for the treatment of moderate-to-severe acute pain in adults. Approved by the...

Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsAmgen maintains a massive, diversified portfolio of medicines serving approximately 17 million patients globally...

Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock

Key PointsVertex Pharmaceuticals' core business is rock-solid, but it is also slowly expanding into new areas...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Bearish Sentiment

Job displacement

Market bubble / overvaluation

Loss of human oversight / control

Killer robots 🤖

As AI spending accelerates across hyperscalers and valuations climb to historic highs, investors and workers alike are increasingly debating the risks the technology poses - from job displacement to fears about losing human oversight over increasingly autonomous systems. What do you think is the biggest threat AI poses? Vote and explain your reasoning in the comments.

Current Price	$520.73
Prev Close	$510.72
Open	$522.32
Dividend Yield	0.00%
50-Day Moving Average	$511.10
Beta	0.54
Avg. Volume	1.2M
PE Ratio	29.71

52-Week High	$560.25
52-Week Low	$374.17
Market Capitalization	$129.45B
EPS (Annual)	$15.32
Price to Book	6.39
Revenue Per Employee	$1.89M

Feed

News

Sentiment

Earnings

Fundamentals

Info

VRTX Fundamentals